Gene: EBPL
Official Full Name: EBP likeprovided by HGNC
Gene Summary: Predicted to enable cholestenol delta-isomerase activity. Predicted to be involved in sterol metabolic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24746 | EBPL Knockout cell line (HeLa) | Human | EBPL | 1:3~1:6 | Negative | Online Inquiry |
KO24747 | EBPL Knockout cell line (HCT 116) | Human | EBPL | 1:2~1:4 | Negative | Online Inquiry |
KO24748 | EBPL Knockout cell line (HEK293) | Human | EBPL | 1:3~1:6 | Negative | Online Inquiry |
KO24749 | EBPL Knockout cell line (A549) | Human | EBPL | 1:3~1:4 | Negative | Online Inquiry |
EBPL Gene Knockout Cell Lines are genetically modified cell lines engineered to lack the expression of the EBPL (Epidermal Barrier Protein-Like) gene, a critical component involved in the maintenance of skin barrier function and cellular homeostasis. By utilizing advanced CRISPR-Cas9 technology, these knockout cell lines facilitate precise and efficient gene editing, allowing researchers to elucidate the role of EBPL in various biological processes, including cell proliferation, differentiation, and response to external stimuli.
The primary function of EBPL Gene Knockout Cell Lines is to serve as a powerful tool for studying the molecular pathways associated with epidermal development and pathologies such as skin disorders, cancer, and wound healing. The lack of EBPL expression enables researchers to investigate the downstream effects on keratinocyte behavior and explore compensatory mechanisms undertaken by neighboring cells, thus providing insights into the resilience of the epidermal barrier under stress conditions.
Scientifically, these cell lines hold significant importance in both basic and translational research settings. They can be utilized for drug screening, as understanding the implications of EBPL depletion may lead to the discovery of novel therapeutic strategies that target underlying mechanisms in skin pathologies. Moreover, the applicability of these cell lines can extend to evaluating the effectiveness of cosmetic ingredients designed to promote skin barrier function.
What sets EBPL Gene Knockout Cell Lines apart from traditional cell models is their specificity and the robust genetic manipulation that allows high reproducibility in experimental setups. Compared to standard parental cell lines, these knockout models offer clearer data on gene function and interaction, increasing confidence in experimental outcomes.
For researchers and clinicians focused on dermatological health and regenerative medicine, the ability to utilize these specialized knockout cell lines represents a significant advancement. They provide a unique platform for exploring gene functions in conditions pertinent to skin biology and enhance the understanding of gene-environment interactions.
Our company prides itself on its expertise in developing highly characterized biological products tailored to meet the needs of scientists and clinicians alike. With a commitment to quality and innovation, we provide foundational tools that accelerate research and contribute to advancements in health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.